The known cicada fauna of the Republic of Trinidad and Tobago is identified. Calyria hyperochelabrys n. sp., Carineta trinidadensis n. sp., and Herrera grammosticta n. sp. are described as new. The first records of Fidicinoides descampsi Boulard Martinelli, 1996, Proarna hilaris (Germar, 1834), Guyalna bogotana (Distant, 1892a), Majeorona aper (Walker, 1850), Taphura boulardi Sanborn, 2011a, Carineta matura Distant, 1892b, and Herrera nigropercula Sanborn, 2020b are provided. The first reports for the genera Guyalna Boulard Martinelli, 1996, Majeorona Distant, 1905d, Calyria Stål, 1862, Carineta Amyot Audinet-Serville, 1843 and Herrera Distant, 1905c and the tribes Parnisini Distant, 1905e and Carinetini Distant, 1905c are represented by the records for the new species and new records. The first records of Proarna hilaris (Germar, 1830) for Anegada, Antigua, Grenada, Canoun Island, Mayreau Island and Union Island in the Grenadines, Little St. James, Little Thatch Island, Montserrat, Mosquito Island, and St. Kitts, Proarna palisoti (Metcalf, 1963a) for Navarro Island, Majeorona aper (Walker, 1850) for Grenada, and Ariasa albimaculosa Sanborn, 2016c for Bonaire are provided to increase the known distributions of these species and the Caribbean fauna. The currently known cicada fauna for Trinidad is increased here to 15 species representing ten genera, four tribes and two subfamilies. Only Quesada gigas (Olivier, 1790) is known currently from Tobago.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11646/zootaxa.4838.4.7 | DOI Listing |
Microorganisms
January 2025
Department of Para-Clinical Sciences, University of the West Indies, St. Augustine Campus, St. Augustine 330912, Trinidad and Tobago.
This systematic review evaluated the effectiveness and side effects of various COVID-19 vaccines, with a focus on Trinidad and Tobago. The Pfizer-BioNTech and Moderna vaccines demonstrated the highest efficacy, particularly against COVID-19 variants, while Janssen and Sinopharm were comparatively less effective. mRNA vaccines, such as Pfizer-BioNTech and Oxford-AstraZeneca, were associated with more frequent and severe side effects, including soreness, fever, and cardiovascular issues.
View Article and Find Full Text PDFPLoS One
January 2025
Equity Research and Innovation Center, Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Background: Accurate assessment of cardiovascular disease (CVD) risk is crucial for effective prevention and resource allocation. However, few CVD risk estimation tools consider social determinants of health (SDoH), despite their known impact on CVD risk. We aimed to estimate 10-year CVD risk in the Eastern Caribbean Health Outcomes Research Network Cohort Study (ECS) across multiple risk estimation instruments and assess the association between SDoH and CVD risk.
View Article and Find Full Text PDFBMJ Evid Based Med
January 2025
Research for Health Department, Science Division, World Health Organization, Geneva, Switzerland
J Investig Med High Impact Case Rep
January 2025
The University of the West Indies, St. Augustine, Trinidad and Tobago.
We describe a 30-year-old Caribbean-Black woman with a clinical presentation suggestive of a transient ischemic attack (TIA) with no conventional cerebrovascular risk factors, albeit with a newly diagnosed quadricuspid aortic valve (QAV) with moderate aortic regurgitation (AR). Although QAV is a recognized congenital cardiac defect, its association with TIA remains elusive. This case highlights the importance of considering potential atypical etiologies, such as QAV, in the evaluation and management of young patients presenting with cerebrovascular events.
View Article and Find Full Text PDFLancet Reg Health Am
February 2025
Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!